Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Lincoff

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|August 14, 2001
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury modelK Wang, Z Zhou, X Zhou, et al.
Circulation|March 14, 2001
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) TrialS R Steinhubl, S G Ellis, K Wolski, et al.
Journal of the American College of Cardiology|March 15, 1997
Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury modelA M Lincoff, J G Furst, S G Ellis, et al.
Journal of the American College of Cardiology|March 1, 1991
Percutaneous support devices for high risk or complicated coronary angioplastyA M Lincoff, J J Popma, S G Ellis, et al.
The American Journal of Cardiology|December 30, 1999
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])]M A Robbins, S P Marso, K Wolski, et al.
Journal of the American College of Cardiology|April 1, 1992
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profileA M Lincoff, J J Popma, S G Ellis, et al.
Circulation|August 15, 2001
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitusS H Park, S P Marso, Z Zhou, et al.
Chest|February 7, 2001
Antithrombotic therapy in patients undergoing percutaneous coronary interventionJ J Popma, E M Ohman, J Weitz, et al.
Circulation|September 15, 1996
Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplastyL A Guzman, V Labhasetwar, C Song, et al.
The American Journal of Medicine|October 6, 2000
Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery diseaseJ G Peterson, E J Topol, S K Sapp, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|August 14, 2001
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury modelK Wang, Z Zhou, X Zhou, et al.
Circulation|March 14, 2001
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) TrialS R Steinhubl, S G Ellis, K Wolski, et al.
Journal of the American College of Cardiology|March 15, 1997
Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury modelA M Lincoff, J G Furst, S G Ellis, et al.
Journal of the American College of Cardiology|March 1, 1991
Percutaneous support devices for high risk or complicated coronary angioplastyA M Lincoff, J J Popma, S G Ellis, et al.
The American Journal of Cardiology|December 30, 1999
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])]M A Robbins, S P Marso, K Wolski, et al.
Journal of the American College of Cardiology|April 1, 1992
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profileA M Lincoff, J J Popma, S G Ellis, et al.
Circulation|August 15, 2001
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitusS H Park, S P Marso, Z Zhou, et al.
Chest|February 7, 2001
Antithrombotic therapy in patients undergoing percutaneous coronary interventionJ J Popma, E M Ohman, J Weitz, et al.
Circulation|September 15, 1996
Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplastyL A Guzman, V Labhasetwar, C Song, et al.
The American Journal of Medicine|October 6, 2000
Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery diseaseJ G Peterson, E J Topol, S K Sapp, et al.
Pageof 12